IDiyas

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Douglas L Wren

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:

goldMedal13 out of 932 
 
Syntex (u.s.a.) Inc.
 patents

Years Active: 1983-2004

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6790848 - 4-piperazinylindole derivatives with 5-HT6 receptor affinity (2004-09-14),
2. 6340756 - Process for preparing a 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative (2002-01-22),
3. 6218568 - Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative (2001-04-17),
4. 6215017 - Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative (2001-04-10),
5. 6040446 - Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) (2000-03-21),
6. 5492914 - 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]i (1996-02-20),
7. 5248788 - Process for preparing allenic prostanoic acid derivatives (1993-09-28),
8. 4916238 - Process for preparing allenic prostanoic acid derivatives (1990-04-10),
9. 4912235 - Processes and intermediates for making 16-phenoxy- and 16-substituted (1990-03-27),
10. 4804787 - Processes and intermediates for making 16-phenoxy and 16-substituted (1989-02-14),
11. 4780562 - Processes and intermediates for making 16-phenoxy and 16-substituted (1988-10-25),
12. 4600785 - Processes and intermediates for making 16-phenoxy and 16-substituted (1986-07-15),
13. 4418206 - 9-Deoxy-9-methylene derivatives of (dl)-16-phenoxy and 16-phenoxy (1983-11-29),

Title: The Innovative Mind of Douglas L. Wren

Introduction

Douglas L. Wren is a remarkable inventor based in Palo Alto, California, known for his significant contributions to the field of pharmaceutical science. With a strong portfolio consisting of 13 patents, Wren has made substantial advancements in the development of compounds targeting various receptors within the brain.

Latest Patents

Among his latest patents, Wren has developed compounds such as "4-piperazinylindole derivatives with 5-HT6 receptor affinity" and a "Process for preparing a 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative." These innovations showcase his dedication to enhancing drug efficacy for mental health treatments and other medical applications.

Career Highlights

Wren is currently employed at Syntex (U.S.A.) Inc., where he continues to drive innovation in the pharmaceutical industry. His work is pivotal in addressing unmet medical needs through the creation of novel therapeutic options.

Collaborations

Throughout his career, Wren has collaborated with talented individuals such as Colin C. Beard and Gary F. Cooper. Together, they have worked on groundbreaking projects that have the potential to transform patient care and treatment outcomes.

Conclusion

Douglas L. Wren stands out as a prominent inventor in the realm of pharmaceuticals. His patents reflect a commitment to innovation that not only advances scientific knowledge but also has the potential to improve the lives of many individuals. As Wren continues his work at Syntex (U.S.A.) Inc., the impact of his contributions will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…